Tuesday, January 29, 2019 12:50:04 PM
Feb 18-21 San Francisco
Alzheimer Society International Congress (ASIC 2019)
ASIC 2019 is a leading forum in Alzheimer research and dementia care. The Congress will highlight the latest accomplishments in Alzheimer research and best practice in patient care.
The theme of the 2019 Congress is “International United Front Against Alzheimer's”.
ASIC 2019 encourages new concepts and hypotheses on the etiology and potential prevention or treatment therapy, and best practice in Alzheimer’s and Dementia care. New ideas and alternatives to Amyloid cascade hypothesis such as Tau hypothesis, Calcium hypothesis, Inflammation hypothesis, Cholinergic and Oxidative stress hypothesis, Glucose hypometabolism, Endocrine pathway, Bacteria-derived metabolites and other new ideas with supporting data are welcome at the ASIC.
NEW FEATURES OF THE ASIC 2019:
<> Presenting latest findings in Alzheimer research and best practices in dementia patient care.
<> Featuring alternative approaches to the amyloid hypothesis.
<> Launching the UNITED FRONT AGAINST ALZHEIMER'S, to fund innovative approaches and clinical trials in Alzheimer's.
<> Formulating a new strategy to find a prevention or a cure of Alzheimer's by 2025.
<> Introducing the GLOBAL VIRTUAL ALZHEIMER COMMUNITY to collaborate in research and practices in dementia patient care.
MEETING VENUE
The ASIC 2019 will be held at the San Francisco Airport CROWNE PLAZA:
1177 Airport Boulevard, Burlingame, CA 94010
The hotel is conveniently located within 1.5 miles from the San Francisco International Airport, and 15 miles from downtown San Francisco. For more information about hotel and reservation, please visit Hotel Information.
Dr. Christopher Missling (*)
Anavex Life Sciences Corp.
New York, NY 10019 USA
http://www.alzint.com/presenters.html
Recent AVXL News
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
- Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference • GlobeNewswire Inc. • 11/26/2025 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/25/2025 09:31:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 12:30:48 PM
- Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/25/2025 12:30:00 PM
- Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference • GlobeNewswire Inc. • 11/19/2025 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 • GlobeNewswire Inc. • 11/18/2025 12:30:00 PM
- Anavex shares collapse after CHMP issues negative signal on Alzheimer’s therapy • IH Market News • 11/14/2025 01:45:51 PM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
